C. Ferreira

发表

G. Giaccone, M. Epping, C. Ferreira, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Bioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and Challenges

Fabio Passetti, C. Ferreira, N. A. Jorge, 2012, Front. Gene..

Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean.

G. Rabinovich, A. Valencia, R. Dienstmann, 2021, The Lancet. Oncology.

SpliceProt: A protein sequence repository of predicted human splice variants

C. Ferreira, A. F. Paes Leme, F. Passetti, 2014, Proteomics.

Splice variants in the proteome: a promising and challenging field to targeted drug discovery.

C. Ferreira, F. Costa, F. Passetti, 2015, Drug discovery today.

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Jianying Zhou, Erdem Goker, Jun Zhao, 2019, The Lancet.

IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY.

Prasad Adusumilli, Young Tae Kim, Ugo Pastorino, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Brazilian health-care policy for targeted oncology therapies and companion diagnostic testing.

C. Ferreira, P. Ashton-Prolla, M. Achatz, 2016, The Lancet. Oncology.

Making PubMed searching simple: learning to retrieve medical literature through interactive problem solving.

C. Ferreira, M. Vincent, Carlos Gil Ferreira, 2006, The oncologist.

Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.

G. Peters, G. Giaccone, C. Ferreira, 2000, Clinical Cancer Research.

XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy.

R. Dienstmann, C. Ferreira, I. Small, 2009, Urologic oncology.

Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.

G. Giaccone, E. Smit, C. Ferreira, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Access of Patients With Lung Cancer to High Technology Radiation Therapy in Brazil

C. Ferreira, V. Aran, A. Rosa, 2021, JCO global oncology.

Combined Analysis of SNP Array Data Identifies Novel CNV Candidates and Pathways in Ependymoma and Mesothelioma

B. Carvalho, C. Ferreira, F. Passetti, 2015, BioMed research international.

Cisplatin triggers apoptotic or nonapoptotic cell death in Fanconi anemia lymphoblasts in a concentration-dependent manner.

G. Giaccone, C. Ferreira, F. Kruyt, 2003, Experimental cell research.

Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.

C. Barrios, J. R. Pereira, C. Ferreira, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TUCAN/CARDINAL/CARD8 and apoptosis resistance in non-small cell lung cancer cells

G. Giaccone, C. Ferreira, F. Kruyt, 2006, BMC Cancer.

Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study.

C. Ferreira, M. Valadão, E. Linhares, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer—INCAGI004

I. Martins, C. Ferreira, S. Guaraldi, 2022, Supportive Care in Cancer.

A randomized phase III trial of single-agent pemetrexed (P) versus carboplatin and pemetrexed (CP) in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2.

C. Barrios, J. R. Pereira, C. Ferreira, 2012 .

A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I

C. Ferreira, G. Suarez-Kurtz, G. Moralez, 2016, Cancer Chemotherapy and Pharmacology.

Comparison of adenocarcinoma (ACA) and squamous cell carcinoma (SCC) of the uterine cervix in a sub-optimally screened cohort: a population-based epidemiologic study of 51,842 women in Brazil.

L. Thuler, C. Ferreira, A. Nogueira-Rodrigues, 2014, Gynecologic oncology.

Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung cancer.

R. Dienstmann, C. Ferreira, R. Martins, 2007, Clinical lung cancer.

cDNA microarray analysis of human keratinocytes cells of patients submitted to chemoradiotherapy and oral photobiomodulation therapy: pilot study

C. Ferreira, N. A. Jorge, F. Passetti, 2017, Lasers in Medical Science.

Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation.

C. Ferreira, C. Viégas, F. Dias, 2016, Oral oncology.

Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.

C. Ferreira, C. Viégas, F. Dias, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Brazilian Women With Lung Cancer Have a Higher Overall Survival Than Their Male Equivalents: A Cohort Study.

M. Mello, L. Thuler, C. Ferreira, 2020, Clinical lung cancer.

Use of (99m)Tc-doxorubicin scintigraphy in females with breast cancer: a pilot study.

C. Ferreira, B. Gutfilen, P. H. Rosado de Castro, 2015, The British journal of radiology.

Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell lines.

P. Hainaut, C. Ferreira, Emanuela de Moraes, 2009, Cancer letters.

A teenager with lung mucinous adenocarcinoma harboring a KRAS mutation arising in type 1 congenital cystic adenomatoid malformation (CCAM)

C. Ferreira, V. Capelozzi, C. Baldotto, 2015 .

p53 and chemosensitivity.

G. Giaccone, C. Ferreira, C. Tolis, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Carboplatin plus pemetrexed offers superior cost-effectiveness compared to pemetrexed in patients with advanced non-small cell lung cancer and performance status 2.

C. Ferreira, O. U. Garay, M. Zukin, 2015, Lung cancer.

Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.

G. Giaccone, E. Smit, P. Postmus, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Thymidylate synthase inhibition triggers apoptosis via caspases-8 and -9 in both wild-type and mutant p53 colon cancer cell lines.

G. Peters, R. Brakenhoff, C. Ferreira, 2003, European journal of cancer.

Response to “Commentary on: Undertreatment trend in elderly lung cancer patients in Brazil”—Jing-lan Tang, Chun-jie Hou

C. Ferreira, L. Thuler, G. Costa, 2017, Journal of Cancer Research and Clinical Oncology.

Occurrence of other tumors in patients with GIST.

C. Ferreira, M. Valadão, E. Linhares, 2010, Surgical oncology.

Platinum-based second-line treatment in non-small-cell lung cancer: an old new kid on the block?

C. Ferreira, L. H. de Lima Araújo, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors

A. Buzaid, C. Ferreira, R. Munhoz, 2017 .

The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy.

C. Ferreira, A. Nicolini, N. Leighl, 2018, Current drug targets.

Unveiling alterative splice diversity from human oligodendrocyte proteome data.

C. Ferreira, J. Cassoli, D. Martins‐de‐Souza, 2017, Journal of proteomics.

Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer—INCAGI004

I. Martins, C. Ferreira, S. Guaraldi, 2021, Supportive Care in Cancer.

Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

R. Dienstmann, C. Ferreira, I. Small, 2007 .

Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma.

R. Dienstmann, C. Ferreira, I. Small, 2007, International braz j urol : official journal of the Brazilian Society of Urology.

A brick in the wall

C. Ferreira, A. Nogueira-Rodrigues, C. G. Ferreira, 2014, Cancer.

Phase I study of cetuximab (CET) in combination with 5-fluorouracil (5-FU), cisplatin (CP), and radiotherapy (RT) in patients with locally advanced squamous cell anal carcinoma (LAAC)

L. Castro, C. Ferreira, F. Meton, 2008 .

Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells.

G. Giaccone, C. Ferreira, F. Kruyt, 2002, Cancer research.

Phase II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

C. Ferreira, R. Martins, F. Dias, 2007 .

Quality Of Life Using A Summary Score After Neoadjuvant Treatment And Surgery For Rectal Cancer.

I. Martins, C. Ferreira, S. Guaraldi, 2020 .

The Impact of low power laser in the treatment of conditioning-induced oral mucositis: a report of 11 clinical cases and their review.

C. Ferreira, H. Antunes, E. D. S. Ferreira, 2008, Medicina oral, patologia oral y cirugia bucal.

Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in Brazil

R. Dienstmann, C. Barrios, T. Reinert, 2021, JCO global oncology.

Erlotinib (E) combined with cisplatin (C) and radiotherapy (RT) for patients with locally advanced squamous cell cervical cancer: A phase II trial

C. Ferreira, R. Martins, C. Viégas, 2008 .

The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression

G. Giaccone, G. Sozzi, F. Andriani, 2004, Oncogene.

Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario

R. Dienstmann, C. Ferreira, M. Costa e Silva, 2021, Journal of market access & health policy.

Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account?

C. Ferreira, D. Herchenhorn, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality.

C. Ferreira, L. Thuler, V. Aran, 2016, Clinical colorectal cancer.

Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.

C. Ferreira, R. Martins, C. Viégas, 2010, International journal of radiation oncology, biology, physics.

Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.

G. Peters, G. Giaccone, C. Ferreira, 1999, European journal of cancer.

The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries

M. Ramsay, K. Chibale, C. Masimirembwa, 2018, BMC medical education.

Impact of two different comorbidity measures on the 6-month mortality of critically ill cancer patients

Nelson Spector, C. Ferreira, M. Soares, 2005, Intensive Care Medicine.

Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial.

Renato Amaro Zangaro, R. Zângaro, C. Ferreira, 2007, Blood.

Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?

C. Ferreira, A. Garces, E. Paulino, 2015, Cancer Chemotherapy and Pharmacology.

Segtor: Rapid Annotation of Genomic Coordinates and Single Nucleotide Variations Using Segment Trees

Gabriel Renaud, Edson Luiz Folador, Fabio Passetti, 2011, PloS one.

Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil

A. Fabro, C. Ferreira, D. Carraro, 2015, Oncology.

BJRD15268 1..7

C. Ferreira, B. Gutfilen, P. H. Rosado de Castro, 2015 .

Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels

E. Giovannetti, G. Peters, R. Brakenhoff, 2007, British Journal of Cancer.

Analysis of KRAS mutations in colorectal cancer (CRC) patients by gender in a Brazilian cohort of 3,346 patients.

C. Ferreira, M. Bonamino, M. Zalis, 2010 .

Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460.

G. Peters, G. Giaccone, C. Ferreira, 2000, Cancer research.

Lung Cancer Cell Line NCI-H 460 and Mitochondria-controlled Manner in the Non-Small Cell Chemotherapy Triggers Apoptosis in a Caspase-8-dependent Updated

G. Peters, G. Giaccone, C. Ferreira, 2000 .

IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.

S. Hanash, I. Wistuba, C. Behrens, 2016, Cancer research.

Potential impact of mTOR inhibitors on cervical squamous cell carcinoma: A systematic review.

C. Ferreira, G. De Luca Canto, D. Assad, 2016, Oncology letters.

CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin.

G. Giaccone, C. Ferreira, F. Kruyt, 2002, Experimental cell research.

Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer

M. Mamede, C. Ferreira, A. Nogueira-Rodrigues, 2014, Cancer.

Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients.

G. Giaccone, P. Postmus, C. Ferreira, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Severe acute tumor lysis syndrome in patients with germ-cell tumors

C. Ferreira, M. Soares, J. Salluh, 2008, Indian journal of urology : IJU : journal of the Urological Society of India.

Tumor-node-metastasis staging and treatment patterns of 73,167 patients with lung cancer in Brazil

L. Thuler, C. Ferreira, A. Bergmann, 2020, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

Increased incidence, morbidity and mortality rates for lung cancer in women in Brazil between 2000 and 2014: An analysis of three types of sources of secondary data.

L. Thuler, C. Ferreira, A. Bergmann, 2018, Lung cancer.

Novel approaches to the treatment of non-small cell lung cancer.

G. Giaccone, C. Ferreira, C. Huisman, 2002, Critical reviews in oncology/hematology.

Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency

Lianbo Yu, Ayse Selen Yilmaz, Weiqiang Zhao, 2015, PloS one.

The Adolescent and Young Adult With Cancer: State of the Art—Epithelial Cancer

C. Ferreira, A. Nogueira-Rodrigues, A. Melo, 2013, Current Oncology Reports.

XAF1 expression levels in a non-small cell lung cancer cohort and its potential association with carcinogenesis.

C. Ferreira, V. Aran, C. Sternberg, 2017, Oncology reports.

Cancer patent scenario in Brazil: Analysis of competitive advantages

C. Ferreira, V. Aran, D. M. Ferreira, 2017 .

Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients.

R. Reis, C. Ferreira, M. Valadão, 2012, The Journal of surgical research.

Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents.

C. Ferreira, Carlos Gil Ferreira, Cinthya Sternberg, 2014, Cancer treatment reviews.

Chemotherapy: still an essential player in non-small-cell lung cancer treatment? MANAGEMENT PERSPECTIVE

C. Ferreira, C. Baldotto, T. Montella, 2013 .

Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis.

C. Ferreira, C. Viégas, F. Dias, 2017, Oral oncology.

Increasing access to next-generation sequencing in oncology for Brazil.

C. Ferreira, I. Cunha, Marcos Santos, 2019, The Lancet. Oncology.

Interferon‐inducible guanylate binding protein (GBP)‐2: A novel p53‐regulated tumor marker in esophageal squamous cell carcinomas

P. Hainaut, C. Barnas, C. V. de Moura Gallo, 2009, International journal of cancer.

Role of P53 Status on Sensitivity to Thymidylate Synthase Inhibitors and Induction of Apoptosis

C. Ferreira, H. Pinedo, H. Backus, 2002 .

Concurrent chemoradiotherapy for stage III non-small cell lung cancer: correct clinical management as the basis to move beyond.

C. Ferreira, L. Thuler, G. Costa, 2018, Annals of translational medicine.

Cancer immunotherapy: the art of targeting the tumor immune microenvironment

C. Ferreira, J. L. da Silva, A. C. de Melo, 2019, Cancer Chemotherapy and Pharmacology.

Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer.

C. Ferreira, L. Thuler, C. R. A. S. de Azevedo, 2017, Gynecologic oncology.

Prognosis of lung cancer patients with life-threatening complications.

C. Ferreira, É. Azoulay, M. Darmon, 2007, Chest.

Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?

C. Ferreira, M. Zamboni, E. Cronemberger, 2012, Supportive Care in Cancer.

Neoadjuvant Chemotherapy Followed by Chemoradiation in Cervical Carcinoma: A Review

C. Ferreira, L. Thuler, C. R. A. S. de Azevedo, 2016, International Journal of Gynecologic Cancer.

Impact of Previous Tracheotomy as a Prognostic Factor in Patients with Locally Advanced Squamous Cell Carcinoma of the Larynx Submitted to Concomitant Chemotherapy and Radiation

C. Ferreira, F. Dias, I. Small, 2008, ORL.

Mitomycin-C- or cisplatin-based chemoradiotherapy for anal canal carcinoma: long-term results.

L. Castro, C. Ferreira, I. Small, 2011, International journal of radiation oncology, biology, physics.

Melanocytic lesions ≤ 6mm: Prospective series of 481 melanocytic trunk and limb lesions in Brazil

G. Argenziano, C. Ferreira, L. Thuler, 2021, PloS one.

Identical sequence patterns in the ends of exons and introns of human protein-coding genes

Emmanuel Dias-Neto, Gabriel Renaud, Raphael Tavares, 2012, Comput. Biol. Chem..

Life-Threatening Complications Prognosis of Lung Cancer Patients With

C. Ferreira, É. Azoulay, M. Darmon, 2007 .

Effect of age on survival of critically ill patients with cancer*

M. Carvalho, C. Ferreira, M. Soares, 2006, Critical care medicine.

Prevalence of human papillomavirus infection and phylogenetic analysis of HPV-16 E6 variants among infected women from Northern Brazil

C. Ferreira, F. Passetti, W. A. de Mello, 2014, Infectious Agents and Cancer.

Palliative percutaneous nephrostomy in recurrent cervical cancer: a retrospective analysis of 50 consecutive cases.

R. Dienstmann, C. Ferreira, I. Small, 2008, Journal of pain and symptom management.

Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer

C. Ferreira, R. Martins, A. Nogueira-Rodrigues, 2008, Clinical Cancer Research.

Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors.

C. Ferreira, E. Braggio, M. Valadão, 2010, Anticancer research.

Increasing access to immuno-oncology therapies in Brazil

C. Ferreira, S. Stefani, C. Gadelha, 2017, Journal of Cancer Policy.

Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

L. Castro, C. Ferreira, A. Victorino, 2013, Cancer.

Intensified ABVP chemotherapy for the primary treatment of Hodgkin's disease.

C. Ferreira, M. Nucci, R. Portugal, 2002, Oncology reports.

Epidemiological changes in the histological subtypes of 35,018 non-small-cell lung cancer cases in Brazil.

C. Ferreira, L. Thuler, G. Costa, 2016, Lung cancer.

snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma

Fabio Passetti, C. Ferreira, F. Passetti, 2017, PloS one.

Lung cancer in Brazil

C. Barrios, C. Ferreira, G. Lopes, 2018, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

Functional analysis of polymorphisms in the COX-2 gene and risk of lung cancer

C. Ferreira, J. R. Lapa e Silva, V. Aran, 2017, Molecular and clinical oncology.

Different antiproliferative effects of matuzumab and cetuximab in A431 cells are associated with persistent activity of the MAPK pathway.

C. Ferreira, Ricardo L A Silva, R. Albano, 2009, European journal of cancer.

A cross-sectional study examining the expression of splice variants K-RAS4A and K-RAS4B in advanced non-small-cell lung cancer patients.

C. Ferreira, V. Aran, Fabiane Carvalho de Macedo, 2018, Lung cancer.

Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab

C. Ferreira, M. Caetano, C. Sternberg, 2011, Molecular Cancer.

Phase II trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive bladder cancer: Preliminary results.

R. Dienstmann, C. Ferreira, D. Herchenhorn, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Amyloid-like fibrils are not detected in non-small cell lung cancer tissue samples

P. Faria, C. Ferreira, C. Sternberg, 2012, Medical Oncology.

Correspondence re: L. Yang et al., Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res., 63: 831-837, 2003.

C. Ferreira, F. Kruyt, A. Chęcińska, 2003, Cancer research.

Dealing with lung cancer in the COVID-19 scenario (A review)

C. Ferreira, V. Aran, M. Zamboni, 2020, Molecular and clinical oncology.

Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells

C. Ferreira, R. Albano, L. Bardella, 2009, British Journal of Cancer.

Reply to phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

C. Ferreira, L. Olivatto, 2014, Cancer.

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS G12C mutation: a randomised, open-label, phase 3 trial

C. Dooms, Melissa L. Johnson, S. Novello, 2023, The Lancet.

Streptococcal bacteraemia in patients submitted to hematopoietic stem cell transplantation: the role of tooth brushing and use of chlorhexidine.

L. Bouzas, C. Ferreira, I. Small, 2010, Medicina Oral.

KRAS mutation profile in colorectal cancer patients in Brazil: A cohort of 989 individuals.

C. Ferreira, M. Bonamino, M. Zalis, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung cancer in developing countries: access to molecular testing.

C. Ferreira, 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Undertreatment trend in elderly lung cancer patients in Brazil

C. Ferreira, L. Thuler, G. Costa, 2017, Journal of Cancer Research and Clinical Oncology.

Erlotinib in symptomatic brain metastases from a lung adenocarcinoma with a sensitizing EGFR mutation.

C. Ferreira, J. S. da Silveira, C. Baldotto, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Erlotinib in Symptomatic Brain Metastases &ROMA,UNG!DENOCARCINOMA7ITHA 3ENSITIZING%'&2-UTATION

C. Ferreira, C. Baldotto, M. Zukin, 2012 .

Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT).

L. Livi, E. Felip, P. Ward, 2023, Journal of Clinical Oncology.

Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer

C. Ferreira, H. K. Pimenta-Inada, A. Nogueira-Rodrigues, 2017, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

P1.02-083 Gene Fusion Profile in Lung Adenocarcinoma Patients in Brazil: Topic: Other Mutations in Thoracic Malignancies

M. Reis, C. Ferreira, G. Torrezan, 2017 .

Survival and prognostic factors in patients with non-small cell lung cancer treated in private health care.

C. Ferreira, A. Victorino, L. Araújo, 2014, Revista brasileira de epidemiologia = Brazilian journal of epidemiology.